The purpose of this study is to evaluate the effectiveness of group therapy for cigarette smoking cessation. The group meets for 8 sessions and includes education and group discussion about the effects of smoking and ways to cope with withdrawal symptoms and other challenges to maintaining abstinence. In one condition, the groups also learn techniques based on cognitive therapy, to help cope with negative feelings.

Condition	Treatment or Intervention	Phase
Smoking	Behavior: cognitive behavior therapy	Phase I Phase II

Further Study Details: 

Primary Outcomes: cigarette smoking abstinence
Secondary Outcomes: cognitive coping skills; depressive symptoms; acceptance; distress tolerance
Expected Total Enrollment:  240

The comparison condition is the same length as the cognitive behavior therapy condition but omits the cognitive restructuring component. In both conditions, smokers prepare for a quit date by using scheduled reduced smoking, which involves smoking on a set schedule that gradually reduces the number of cigarettes smoked. Post-treatment assessments occur one week after the end of treatment, and at 3-month followup.

Pre- and post-treatment assessments include measures of coping skills and emotional acceptance, as well as smoking rate.

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Regular daily smokers interested in quitting

Exclusion Criteria:

• Significant suicidal ideation

Heather M Schloss, BA      202-885-1784    hs3467a@american.edu
David A Haaga, Ph.D.      202-885-1718    dhaaga@american.edu

District of Columbia
      American University, Washington,  District of Columbia,  20016-8062,  United States; Recruiting

Study chairs or principal investigators

David A Haaga, Ph.D.,  Principal Investigator,  American University   

Study ID Numbers:  2R15CA077732-02A1; 2R15CA077732-02A1
Record last reviewed:  March 2005
Last Updated:  March 18, 2005
Record first received:  March 1, 2005
ClinicalTrials.gov Identifier:  NCT00104481
Health Authority: United States: Institutional Review Board (Awaiting confirmation)
ClinicalTrials.gov processed this record on 2005-04-08